MRI Evaluation of Cases of Mucormycosis after Covid-19

ABSTRACT

Introduction: COVID-19 spread was due to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Even today, COVID cases are being continually recorded. On this basis, it can be said that there is still the danger of COVID-19 cases getting increased at a rapid rate. There is no way of distinguishing the clinical findings and radiological findings of secondary fungal infection from that of COVID-19 pneumonitis and pneumonia. Aim: To Assess the MRI Evaluation of Cases of Mucormycosis after COVID-19”. Material and Methods: In the current study, the researcher conducted an observational study at Pacific Medical College, Udaipur, Rajasthan, India. Data for all the confirmed mucormycosis cases among patients with and without COVID-19 reported from September 2020 to December 2020, for the current study was collected. The researcher used SPSS Statistics 21.0 for performing an analysis of the data obtained from the health care centre. The descriptive statistics were measured and analysed using frequencies, mean, standard deviations, and median. Results: Out of the 286 cases, 65% (N = 185) had CAM (COVID-19 Associated Mucormycosis), with the mean age of 52 (SD = 16) years. Furthermore, 75% (N = 214) of the entire study population was male;and the remaining 25% (N = 72) were female. The prevalence of CAM was 0.28% and the range was 0.04% to 0.60%;on the other hand, CAM prevalence in ICU patients was determined to be 1.9% and the range was o.68% to 2%. Conclusion: From the current results, it can be concluded that Uncontrolled Diabetes Mellitus, found to be among 63% of the participants, was one of the common diseases in both CAM as well as non-CAM groups. In addition, the rhino-orbital area was among the most well-known sites of mucormycosis, with 58% participants, followed by rhino-orbital-cerebral, pneumonic, and other such areas.